Natixis Investment Managers International’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Natixis Investment Managers International's PFE Position: Q3 2022 in Review
Natixis Investment Managers International sold out of Pfizer (PFE) in Q3 2022, closing a stake of 56,793 shares — an estimated $2.98M sold.
Natixis Investment Managers International first reported a position in PFE in Q4 2014 and held it in 17 quarters. The position peaked at $3.92M in Q3 2018. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Natixis Investment Managers International reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 56,793 Pfizer shares in Q3 2022, an estimated $2.98M.
- Natixis Investment Managers International first reported a position in Pfizer in Q4 2014 and held it in 17 quarters.
- Natixis Investment Managers International's Pfizer position peaked at $3.92M in Q3 2018.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.